Am J Cardiol

1. KOZIELSKI J, Orczykowski M, Swierzynska-Wodarska E, Szumowski L, et al
   Left atrial mechanical and hemodynamic function after ablation of atrial fibrillation.
   Am J Cardiol. 2026 Feb 10:S0002-9149(26)00048.
   

   >> Share

   
   

   
   Am J Emerg Med

2. SIRIN I, Vural NV, Menekse TS, Safak S, et al
   Response heterogeneity in patients with vagal-refractory paroxysmal supraventricular tachycardia treated with adenosine: A retrospective study.
   Am J Emerg Med. 2026;101:22-28.
   

   >> Share

   
   
3. BAUMEISTER B, Bassfeld E, Evangelatos N
   Aconitine poisoning as a rare cause of pulseless diffuse ventricular arrhythmia: a case report.
   Am J Emerg Med. 2026;103:99-104.
   

   >> Share

   
   

   
   Ann Thorac Surg

4. HODGES KE, McCarthy PM, Habib RH, Robinson E, et al
   Increasing But Variable Use of Surgical Treatment of Atrial Fibrillation: An Update from the STS Adult Cardiac Surgery Database.
   Ann Thorac Surg. 2026 Feb 10:S0003-4975(26)00118.
   

   >> Share

   
   

   
   Circ Res

5. ELSAAFIEN K, Kirchner MK, Baumer-Harrison C, Tan Y, et al
   Oxytocin and Vasopressin Cross Talk Within the Brain Increases Blood Pressure.
   Circ Res. 2026;138:e327322.
   

   >> Share

   
   
6. SIMON-CHICA A, Quintanilla JG, Torroja C, Couselo-Seijas M, et al
   Cardiac Macrophages and Fibroblasts Modulate Atrial Fibrillation Maintenance.
   Circ Res. 2026 Feb 10. doi: 10.1161/CIRCRESAHA.125.326291.
   

   >> Share

   
   

   
   Circulation

7. HAIMOVICH JS, Kany S, Chang Y, Borowsky LH, et al
   Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial.
   Circulation. 2026;153:367-378.
   

   >> Share

   
   
8. VIRK SA, Kalman JM
   Stressor-Associated Atrial Fibrillation: Triggering the Arrhythmia or Unmasking the Substrate?
   Circulation. 2026;153:379-381.
   

   >> Share

   
   

   
   Clin Cardiol

9. FAIZAN MA, Rehman T, Dandamudi M, Menon JA, et al
   Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation.
   Clin Cardiol. 2026;49:e70263.
   

   >> Share

   
   

   
   Eur Heart J

10. SEPEHRI SHAMLOO A, Dagres N
    Subcutaneous implantable cardioverter-defibrillators enter maturity: HONEST lessons from a nationwide cohort.
    Eur Heart J. 2026 Feb 9:ehaf1094. doi: 10.1093/eurheartj/ehaf1094.
    

    >> Share

    
    
11. CAI L, Wan H, Sun Y, Middeldorp ME, et al
    Atrial fibrillation: an underappreciated complication of diabetes.
    Eur Heart J. 2026 Feb 11:ehag044. doi: 10.1093.
    

    >> Share

    
    
12. CREA F
    Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension.
    Eur Heart J. 2026;47:649-654.
    

    >> Share

    
    
13. HESSELLUND AK, Svendsen JH, Diederichsen SZ
    Hypokalaemia and atrial fibrillation: a data-driven perspective.
    Eur Heart J. 2026 Feb 13:ehag058. doi: 10.1093.
    

    >> Share

    
    
14. ROSSI FB, Sammarco A, Seccia TM
    Potassium and aldosterone as determinants of new-onset atrial fibrillation.
    Eur Heart J. 2026 Feb 13:ehag057. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

15. KOLDENHOF T, Borof K, Van Gelder IC, Tieleman RG, et al
    Heart rate in early rhythm control therapy in patients with atrial fibrillation.
    Heart. 2026 Feb 9:heartjnl-2025-326878. doi: 10.1136/heartjnl-2025-326878.
    

    >> Share

    
    

    
    Int J Cardiol

16. WANG Z, Hu Y, He H, Tu J, et al
    Systemic inflammatory indices, cardiac conduction disorders, and atrial fibrillation: Phenotype-specific associations and incremental discrimination in the China National Health Survey (CNHS).
    Int J Cardiol. 2026;450:134224.
    

    >> Share

    
    

    
    J Am Coll Cardiol

17. GERSTENFELD EP, Schmidt B, Natale A, Nair D, et al
    Pulsed Field Ablation vs Standard Radiofrequency Ablation for Typical Atrial Flutter: ADVANTAGE AF Trial Substudy.
    J Am Coll Cardiol. 2026 Feb 6:S0735-1097(26)00055.
    

    >> Share

    
    
18. HUSSEIN AA, Wazni OM
    Pulsed-Field vs Radiofrequency Ablation of Typical Atrial Flutter: Solidifying the Versatility of Pulsed Field Ablation.
    J Am Coll Cardiol. 2026 Feb 5:S0735-1097(26)00206.
    

    >> Share

    
    

    
    J Cardiovasc Electrophysiol

19. DORIAN P, Alings M, Coutu B, Ip JE, et al
    Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 Study.
    J Cardiovasc Electrophysiol. 2026 Feb 10. doi: 10.1111/jce.70287.
    

    >> Share

    
    
20. TARTAGLIA E, Bucci T, Askarinejad A, Rossi M, et al
    Prognostic Impact of New-Onset Atrial Fibrillation After Cardiac Arrest: Observations From a Federated Research Network.
    J Cardiovasc Electrophysiol. 2026 Feb 10. doi: 10.1111/jce.70288.
    

    >> Share

    
    
21. ENEVOLDSEN S, Elbrond VS, Thomsen MB, Calloe K, et al
    Characterization of the Porcine Cardiac Conduction System and Electrocardiogram: Implications for Using the Pig in Translational Arrhythmia Research.
    J Cardiovasc Electrophysiol. 2026;37:242-253.
    

    >> Share

    
    
22. CASTRICHINI M, Ferreira Felix I, Karlinski Vizentin V, Garmany R, et al
    Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single-Arm Meta-Analysis.
    J Cardiovasc Electrophysiol. 2026;37:268-274.
    

    >> Share

    
    
23. SAWALHA K, Kusumoto F, Al-Akchar M, Sadeq A, et al
    Catheter Ablation Versus Medical Therapy as First-Line Treatment for Ventricular Electrical Storm: A Systematic Review and Meta-Analysis.
    J Cardiovasc Electrophysiol. 2026;37:305-312.
    

    >> Share

    
    
24. WENZEL JP, Hatahet S, Eitel C, Abdessadok R, et al
    Inflammatory and Myocardial Biomarker Response Following Pulmonary Vein Isolation: Cryoballoon Versus Balloon-in-Basket Pulsed Field Ablation.
    J Cardiovasc Electrophysiol. 2026;37:296-304.
    

    >> Share

    
    
25. IP JE, Badie N, Rashtian M, Nair DG, et al
    Novel Pacing Mode Conserves Battery in Dual-Chamber Leadless Pacemakers.
    J Cardiovasc Electrophysiol. 2026;37:338-346.
    

    >> Share

    
    
26. SAHA SA, Rosemas S, Sarkar S, Ramos V, et al
    A Large, Real-World Cohort Analysis of Arrhythmia Detection and Therapeutic Interventions in Patients With Insertable Cardiac Monitors and Long-Term Monitoring.
    J Cardiovasc Electrophysiol. 2026;37:359-373.
    

    >> Share

    
    
27. HADDADIN F, Kessler SA, Prisco A, Zhi E, et al
    A Novel Workflow Combining Artificial Intelligence-Twelve Lead Electrocardiographic Analysis and Real-Time Mapping for Hemodynamically Unstable Ventricular Tachycardia.
    J Cardiovasc Electrophysiol. 2026;37:381-389.
    

    >> Share

    
    
28. HORNOF J, Hozman M, Herman D, Romanenko O, et al
    Acute Efficacy of Pulsed-Field Ablation of the Mitral Isthmus Using a Pentaspline Catheter and Two Different Ablation Settings.
    J Cardiovasc Electrophysiol. 2026;37:390-399.
    

    >> Share

    
    
29. AREVALO E, Erazo C, Serpa F, Rivera A, et al
    Prognostic Impact of Early Recurrence Following Pulsed Field Ablation: A Meta-Analysis.
    J Cardiovasc Electrophysiol. 2026;37:429-433.
    

    >> Share

    
    
30. SMITH A, Ortman M, Andriulli J, Russo AM, et al
    Pacemaker and ICD Programming Adherence With Evidence-Based Recommendations.
    J Cardiovasc Electrophysiol. 2026;37:424-428.
    

    >> Share

    
    
31. KANZAKI Y, Morishima I, Shimojo K, Tanaka Y, et al
    Localized Conduction Delay in the Proximal Bundle Branch Region in Bundle Branch Reentrant Ventricular Tachycardia Without Structural Heart Disease.
    J Cardiovasc Electrophysiol. 2026;37:438-442.
    

    >> Share

    
    

    
    J Electrocardiol

32. OMUR SE, Zorlu C, Genc Tapar G, Karaman K, et al
    Electrocardiographic atrial cardiomyopathy markers in sinus rhythm and the risk of incident atrial fibrillation and ischemic stroke a retrospective cohort study.
    J Electrocardiol. 2026;95:154208.
    

    >> Share

    
    
33. VIJAYAKUMAR R, Yates TA, McGilvray M, Razo N, et al
    Mechanisms of atrial fibrillation in mitral regurgitation patients: Insights from noninvasive electrocardiographic imaging.
    J Electrocardiol. 2026;95:154209.
    

    >> Share

    
    

    
    J Interv Card Electrophysiol

34. LIMA FRG, Aguiar KA, de Castro Costa AJS, Amorim ACLB, et al
    Prevalence of atrial fibrillation and conduction abnormalities in Chagas disease: a systematic review and an updated meta-analysis.
    J Interv Card Electrophysiol. 2026 Feb 10. doi: 10.1007/s10840-026-02243.
    

    >> Share

    
    

    
    J Thromb Thrombolysis

35. ZHAO Y, Lian J, Wei M, Chen W, et al
    Atrial cardiopathy and thrombus composition in acute ischemic stroke: histological examination reveals insights into etiology and outcomes.
    J Thromb Thrombolysis. 2026;59:64-75.
    

    >> Share

    
    

    
    Lancet

36. KELSHIKER MA, Bachtiger P, Petri CF, Nakhare S, et al
    Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial.
    Lancet. 2026 Jan 28:S0140-6736(25)02156-7. doi: 10.1016/S0140-6736(25)02156.
    

    >> Share

    
    

    
    N Engl J Med

37. BUNDGAARD H, Zheng C, Jons C
    Potassium Levels and Risk of Ventricular Arrhythmias. Reply.
    N Engl J Med. 2026;394:725-726.
    

    >> Share

    
    
38. INGWILLER M
    Potassium Levels and Risk of Ventricular Arrhythmias.
    N Engl J Med. 2026;394:725.
    

    >> Share

    
    
39. YUAN Y, Tang Y, Wu Y
    Potassium Levels and Risk of Ventricular Arrhythmias.
    N Engl J Med. 2026;394:725.
    

    >> Share

    
    
40. ABRAMOV D, Garg J
    Potassium Levels and Risk of Ventricular Arrhythmias.
    N Engl J Med. 2026;394:724-725.
    

    >> Share

    
    
41. HURTADO-TORRES GF
    Potassium Levels and Risk of Ventricular Arrhythmias.
    N Engl J Med. 2026;394:724.
    

    >> Share

    
    
42. RIVERA RF, Sciarrone Alibrandi MT
    Potassium Levels and Risk of Ventricular Arrhythmias.
    N Engl J Med. 2026;394:723-724.
    

    >> Share

    
    
43. LIP GYH, Kuzma L
    Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:713-715.
    

    >> Share

    
    

    
    Pacing Clin Electrophysiol

44. KERESTECI AH, Coteli C, Ates AH, Ardali Duzgun S, et al
    Impact of Pulmonary Vein Anatomy on Outcomes in Patients Undergoing Cryoballoon Ablation for Atrial Fibrillation.
    Pacing Clin Electrophysiol. 2026 Feb 13. doi: 10.1111/pace.70154.
    

    >> Share

    
    

    
    PLoS One

45. PIZZI C, Pagliani L, Carbonare LD, Agostoni P, et al
    Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF.
    PLoS One. 2026;21:e0341633.
    

    >> Share

    
    
46. ROSHAN N, Pandit R
    Abnormal calcium release and delayed afterdepolarizations: A comparison of two mathematical models for human ventricular myocytes.
    PLoS One. 2026;21:e0338873.
    

    >> Share

    
    

    
    Thorac Cardiovasc Surg

47. SCHLOMICHER M, Prummer K, Haldenwang P, Moustafine V, et al
    Conduction Disorders after Rapid Deployment Aortic Valve Replacement Compared to Conventional Aortic Valve Replacement.
    Thorac Cardiovasc Surg. 2026;74:99-105.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share